GB8321719D0 - Imidazoline derivative - Google Patents

Imidazoline derivative

Info

Publication number
GB8321719D0
GB8321719D0 GB838321719A GB8321719A GB8321719D0 GB 8321719 D0 GB8321719 D0 GB 8321719D0 GB 838321719 A GB838321719 A GB 838321719A GB 8321719 A GB8321719 A GB 8321719A GB 8321719 D0 GB8321719 D0 GB 8321719D0
Authority
GB
United Kingdom
Prior art keywords
imidazoline derivative
imidazoline
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB838321719A
Other versions
GB2144738A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Priority to GB08321719A priority Critical patent/GB2144738A/en
Publication of GB8321719D0 publication Critical patent/GB8321719D0/en
Priority to JP59164160A priority patent/JPS6051176A/en
Publication of GB2144738A publication Critical patent/GB2144738A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB08321719A 1983-08-12 1983-08-12 Imidazolines Withdrawn GB2144738A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB08321719A GB2144738A (en) 1983-08-12 1983-08-12 Imidazolines
JP59164160A JPS6051176A (en) 1983-08-12 1984-08-03 Novel imidazoline derivative and its preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08321719A GB2144738A (en) 1983-08-12 1983-08-12 Imidazolines

Publications (2)

Publication Number Publication Date
GB8321719D0 true GB8321719D0 (en) 1983-09-14
GB2144738A GB2144738A (en) 1985-03-13

Family

ID=10547197

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08321719A Withdrawn GB2144738A (en) 1983-08-12 1983-08-12 Imidazolines

Country Status (2)

Country Link
JP (1) JPS6051176A (en)
GB (1) GB2144738A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07111812B2 (en) * 1987-06-15 1995-11-29 三菱電機株式会社 Digital playback device
JPH0748285B2 (en) * 1986-10-24 1995-05-24 三菱電機株式会社 Digital playback device

Also Published As

Publication number Publication date
JPS6051176A (en) 1985-03-22
GB2144738A (en) 1985-03-13
JPH0542432B2 (en) 1993-06-28

Similar Documents

Publication Publication Date Title
GB8334499D0 (en) Derivatives
GB8405980D0 (en) N-pyridylpyrazole derivatives
PH22076A (en) Benzocycloalkane derivative
EP0129513A3 (en) Oxamic-acid derivatives
GB2145084B (en) Fredericamycin derivatives
GB8416172D0 (en) Spirosuccinide derivatives
GB8415032D0 (en) 3-phenyl-4-cyano-pyrrole derivatives
GB8412501D0 (en) 3-acylamino-2-oxoazetidine derivative
GB2144119B (en) Fluoromethylthiooxacephalosporin derivatives
DE3475621D1 (en) 2-dioxacycloalkylthiopenem derivatives
GB2146991B (en) Fluorenylalkylimidazole derivatives
EG16589A (en) 2-azacycloalkylthiopenem derivatives
GB2152046B (en) 2-arylbenzothiazoline derivatives
DE3460649D1 (en) Cyanotercyclohexane derivatives
AR243155A1 (en) Benzoamide derivatives
GB8408128D0 (en) Gonadoliberine derivatives
GB8321000D0 (en) Imidazole derivative
GB8321719D0 (en) Imidazoline derivative
ZA84952B (en) Imidazole derivatives
EP0143001A3 (en) Pyrimidoisoquinoline derivatives
IE832167L (en) Imidazoline derivative
JPS57146769A (en) Imidazoline derivative
GB8419592D0 (en) Imidazole derivatives
GB8332862D0 (en) Imidazoline derivatives
GB8330260D0 (en) Tetrahydro-beta-carboline derivatives

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)